ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $119,000 | +11800.0% | 2,244 | +5510.0% | 0.00% | – |
| Q2 2020 | $1,000 | -97.6% | 40 | -95.6% | 0.00% | -100.0% |
| Q4 2015 | $42,000 | -16.0% | 909 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $50,000 | +2.0% | 909 | +1236.8% | 0.00% | 0.0% |
| Q2 2015 | $49,000 | +25.6% | 68 | -37.0% | 0.00% | 0.0% |
| Q1 2015 | $39,000 | +18.2% | 108 | -22.9% | 0.00% | – |
| Q3 2014 | $33,000 | -93.1% | 140 | -99.3% | 0.00% | -100.0% |
| Q4 2013 | $478,000 | +102.5% | 18,720 | +117.7% | 0.01% | +80.0% |
| Q3 2013 | $236,000 | +108.8% | 8,600 | +67.0% | 0.01% | +66.7% |
| Q2 2013 | $113,000 | – | 5,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |